TG
TG
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$31K
Insider Sales
71
$9.53M
Total Volume
$9.56M
100 transactions
Net Activity
$9.50M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$440.41M total
Gottwald William M
10%
$3.62M total
Gottwald James T.
10%
$2.93M total
Gottwald John D
10%
$2.93M total
Tack Carl E. III
Dir
$42K total
Quick Actions
TG has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at TG (TG) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 71 were sales. The total volume of insider trading reached $9.56M.
The net insider activity for TG shows a net selling bias of $9.50M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 147.4K shares valued at $308.59M on Aug 18, 2026.
TG Stock Tumbles 19% As It Incurs Q3 Loss on Soft Construction Demand
Tredegar Stock Price Forecast. Should You Buy TG?
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point
A multiple sclerosis treatment fueled TG Therapeutics’ growth as it made Deloitte’s list for a third straight year.
Avoiding Lag: Real-Time Signals in (TG) Movement
Will Revenue Guidance Raise Change TG Therapeutics Stock Narrative
FAQs About TG Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for TG.